Faculty Opinions recommendation of STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.

Author(s):  
Philip Murphy ◽  
Michail Lionakis
2011 ◽  
Vol 365 (1) ◽  
pp. 54-61 ◽  
Author(s):  
Frank L. van de Veerdonk ◽  
Theo S. Plantinga ◽  
Alexander Hoischen ◽  
Sanne P. Smeekens ◽  
Leo A.B. Joosten ◽  
...  

PLoS ONE ◽  
2011 ◽  
Vol 6 (12) ◽  
pp. e29248 ◽  
Author(s):  
Sanne P. Smeekens ◽  
Theo S. Plantinga ◽  
Frank L. van de Veerdonk ◽  
Bas Heinhuis ◽  
Alexander Hoischen ◽  
...  

2012 ◽  
Vol 32 (6) ◽  
pp. 1213-1220 ◽  
Author(s):  
Tomohiro Hori ◽  
Hidenori Ohnishi ◽  
Takahide Teramoto ◽  
Kohji Tsubouchi ◽  
Takafumi Naiki ◽  
...  

2015 ◽  
Vol 212 (5) ◽  
pp. 619-631 ◽  
Author(s):  
Yun Ling ◽  
Sophie Cypowyj ◽  
Caner Aytekin ◽  
Miguel Galicchio ◽  
Yildiz Camcioglu ◽  
...  

Chronic mucocutaneous candidiasis (CMC) is characterized by recurrent or persistent infections of the skin, nail, oral, and genital mucosae with Candida species, mainly C. albicans. Autosomal-recessive (AR) IL-17RA and ACT1 deficiencies and autosomal-dominant IL-17F deficiency, each reported in a single kindred, underlie CMC in otherwise healthy patients. We report three patients from unrelated kindreds, aged 8, 12, and 37 yr with isolated CMC, who display AR IL-17RC deficiency. The patients are homozygous for different nonsense alleles that prevent the expression of IL-17RC on the cell surface. The defect is complete, abolishing cellular responses to IL-17A and IL-17F homo- and heterodimers. However, in contrast to what is observed for the IL-17RA– and ACT1-deficient patients tested, the response to IL-17E (IL-25) is maintained in these IL-17RC–deficient patients. These experiments of nature indicate that human IL-17RC is essential for mucocutaneous immunity to C. albicans but is otherwise largely redundant.


Sign in / Sign up

Export Citation Format

Share Document